Almost all studies about CDKN1A and melanoma suggest that the up-regulation of CDKN1A expression can inhibit the growth of melanoma cells, accelerate aging, and improve the sensitivity of therapeutic drugs [50, 51]. Here, CDKN1A is linked to melanoma.